Published in Medicine and Law Weekly, March 25th, 2005
The U.S. Food and Drug Administration (FDA) said March 2, 2005, that Crestor, like other drugs in the category known as statins, can have a rare side effect of serious muscle damage.
A clinical trial found that levels of Crestor in Asian patients were double those of Caucasians taking the same dose, increasing the chance of muscle damage.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.